Monoclonal antibodies are redefining therapeutic possibilities in animal health, offering precise, targeted alternatives to traditional treatments. With next-generation innovation expanding into new disease areas and species, changemakers at the forefront examine the opportunities and hurdles that will shape development, approval, and adoption.
- Regulatory pathways – navigating approval processes for novel biologics
- Clinical adoption – driving veterinary education and confidence in new therapies
Time:
3:15pm - 3:45pm
Agenda Track No.:
Track 5
Session Type:
General Session (Presentation)